Connecticut Innovations (CI) invested $13.5 million across 34 transactions during the third quarter of its 2022 fiscal year. CI directed approximate
ly $4.9 million toward healthcare companies, while $4.1 million was allocated across the technology sector. The remaining investment funds spanned areas such as climate-tech, consumer and venture funds.
“We are seeing a rightsizing of the market, which will affect the companies in our portfolio over the next several years,” said Matthew Storeygard, senior managing director of investments at Connecticut Innovations. “However, we continue to see tremendous progress with our portfolio companies, and we look forward to helping them grow as we near the end of the fiscal year.”